共 50 条
Assessment of myocardial scarring by contrast enhanced magnetic resonance imaging in a patient 11 years after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy
被引:2
|作者:
Butz, T.
[1
,2
]
Horstkotte, D.
[2
]
Koerfer, J.
[3
]
Langer, C.
[2
]
Seggewiss, H.
[4
]
Faber, L.
[2
]
机构:
[1] Ruhr Univ Bochum, Dept Cardiol & Angiol, Marienhosp, D-44627 Herne, Germany
[2] Ruhr Univ Bochum, Dept Cardiol, Heart & Diabet Ctr N Rhine Westphalia, Bad Oeynhausen, Germany
[3] Ruhr Univ Bochum, Inst Radiol Nucl Med & Mol Imaging, Heart & Diabet Ctr N Rhine Westphalia, Bad Oeynhausen, Germany
[4] Leopoldina Hosp Schweinfurt, Schweinfurt, Germany
关键词:
Hypertrophic obstructive cardiomyopathy;
Septal ablation;
PTSMA;
Magnetic resonance imaging;
MRI;
Myocardial scar;
VENTRICULAR OUTFLOW TRACT;
D O I:
10.1016/j.ijcard.2008.12.096
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
We report on a 60 year-old male who was one of the first patients who underwent percutaneous transluminal septal myocardial ablation (PTSMA) in our institution in 1996. Contrast enhanced cardiac magnetic resonance imaging (MRI) 11 years after the PTSMA demonstrated extensive scarring, in septal and inferior segments of the left ventricle, and an excellent functional result. It has been previously demonstrated that contrast-enhanced MRI allows detailed evaluation of size and location of septal myocardial infarction induced by PTSMA, and that infarction size detected by MRI correlates well with clinical indexes of infarct size. Our case report underlines the importance of ongoing specialized care and reassessment of patients after PTSMA including continuous clinical risk assessment. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:E3 / E5
页数:3
相关论文